Medicare Enrolled
Dr. Minna Huang, M.D.
Nephrology · Upland, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Huang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Huang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Huang
Dr. Minna Huang is a nephrology specialist in Upland, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Huang performed 8,075 Medicare services across 1,226 unique beneficiaries.
Between the years covered by Open Payments, Dr. Huang received a total of $1,240 from 23 pharmaceutical and/or device companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Huang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 5% volume in CA
$1,240 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,075
Medicare services
Top 5% in CA for nephrology
1,226
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~475 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,587 | $0 | $2 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
626 | $96 | $320 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
405 | $284 | $895 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
354 | $37 | $140 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
302 | $45 | $141 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
284 | $85 | $345 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
280 | $32 | $111 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
230 | $41 | $164 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
210 | $39 | $156 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
115 | $139 | $625 |
| Injection, alteplase recombinant, 1 mg | 102 | $70 | $210 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
85 | $42 | $162 |
| Radiologist review of arm or leg artery image A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels. |
61 | $124 | $480 |
| Arterial catheter insertion, first order branch Placement of a catheter into a primary branch of an artery in the chest or arm. |
53 | $441 | $3,379 |
| Hemodialysis circuit intervention with balloon dilation A procedure to insert a needle or tube into a hemodialysis circuit and dilate the dialysis segment using a balloon, with radiological review. |
43 | $1,014 | $3,946 |
| Fluoroscopic guidance for central vein access device Use of live X-ray imaging to guide the placement or removal of a central vein access device. |
39 | $82 | $328 |
| Removal of tunneled central venous tube This procedure involves the removal of a catheter that has been surgically placed under the skin and threaded into a large vein. |
36 | $120 | $522 |
| Needle or tube insertion into hemodialysis circuit with radiologist review A procedure involving the insertion of a needle or tube into a hemodialysis circuit, accompanied by a review of the procedure by a radiologist. |
35 | $561 | $2,302 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $106 | $530 |
| Replacement of tunneled central venous tube This procedure involves replacing an existing tunneled central venous catheter with a new one. The new tube is inserted through the same tunnel under the skin to maintain vascular access. |
27 | $407 | $2,551 |
| Balloon dilation of dialysis access with radiologist review A minimally invasive procedure to widen a narrowed section of a dialysis access vessel using a balloon catheter. The procedure includes review by a radiologist to ensure proper placement and effectiveness. |
27 | $503 | $1,925 |
| Hemodialysis circuit clot removal and vessel dilation This procedure involves removing or dissolving a blood clot within the hemodialysis circuit and using a balloon to widen the dialysis access segment, with imaging review by a radiologist. |
22 | $1,949 | $7,456 |
| Balloon dilation of vein, initial vein A procedure to widen a vein using a balloon catheter, with radiologist review. |
21 | $1,125 | $4,442 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
21 | $58 | $225 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
20 | $9 | $36 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
16 | $238 | $755 |
| Insertion of tunneled central venous catheter for infusion, age 5+ A surgical procedure to place a long-term catheter into a large vein for delivering medications or fluids. The catheter is tunneled under the skin to reduce infection risk and provide stable access for patients aged 5 and older. |
14 | $683 | $2,717 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
14 | $33 | $127 |
| Hemodialysis clot removal, balloon dilation, and stent placement This procedure involves removing or dissolving a blood clot within the hemodialysis circuit, dilating the dialysis segment with a balloon, and placing a stent, all under radiological review. |
12 | $4,634 | $17,919 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
65.3% medium
33.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,240
Total received (2018-2024)
Avg $177/year across 7 years
Top 48% in CA for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
67
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,240 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$340
2023
$339
2022
$198
2021
$98
2020
$79
2019
$109
2018
$76
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Aurinia Pharma U.S., Inc.
$108
AstraZeneca Pharmaceuticals LP
$83
BIOTRONIK INC.
$39
Otsuka America Pharmaceutical, Inc.
$29
AKEBIA THERAPEUTICS INC
$26
Bard Peripheral Vascular, Inc.
$20
Ardelyx, Inc.
$20
Fresenius USA Marketing, Inc.
$15
Top 3 companies account for 67.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$269
AKEBIA THERAPEUTICS INC
$188
Aurinia Pharma U.S., Inc.
$108
Bard Peripheral Vascular, Inc.
$107
Relypsa, Inc.
$74
Fresenius USA Marketing, Inc.
$63
Otsuka America Pharmaceutical, Inc.
$55
Bayer HealthCare Pharmaceuticals Inc.
$49
BIOTRONIK INC.
$39
GlaxoSmithKline, LLC.
$35
Calliditas Therapeutics US Inc.
$32
Mallinckrodt LLC
$28
Novo Nordisk Inc
$25
Cardinal Health 200, LLC
$22
Amgen Inc.
$22
Ardelyx, Inc.
$20
Xeris Pharmaceuticals, Inc.
$19
LeMaitre Vascular, Inc.
$18
Daiichi Sankyo Inc.
$16
Ultragenyx Pharmaceutical Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
BARD PERIPHERAL VASCULAR, INC.
$12
Travere Therapeutics, Inc.
$10
Top 3 companies account for 45.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ANGIOGUARD RX Emboli Capture Guidewire System · ARTEGRAFT VASCULAR GRAFT · AURYXIA · Auryxia · BENLYSTA · COVERA · FARXIGA · IBSRELA · INJECTAFER · JARDIANCE · JYNARQUE · KEVEYIS · Kerendia · LOKELMA · LUPKYNIS · Parsabiv · Pristine · Pulsar-18 T3 · Rybelsus · SAPHNELO · TARPEYO · Velphoro · Veltassa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Nephrologists within 10 mi
105
Per 100K population
4.8
County median income
$82,184
Nearest hospital
SAN ANTONIO REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Huang is a clinical cardiology specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Huang experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Huang performed 4,587 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Huang receive payments from pharmaceutical companies?
Yes. Dr. Huang received a total of $1,240 from 23 companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Huang's costs compare to other nephrologists in Upland?
Dr. Huang's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Huang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Upland
Browse nephrologists in Upland ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in CA
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in CA
Which CA nephrologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
AKEBIA THERAPEUTICS INC Payments to Doctors
See all physicians who received payments from AKEBIA THERAPEUTICS INC.
By company
Aurinia Pharma U.S., Inc. Payments to Doctors
See all physicians who received payments from Aurinia Pharma U.S., Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology